en
Scientific article
Open access
English

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis

Published inPLOS ONE, vol. 14, no. 5, e0216746
Publication date2019
Abstract

To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage.

eng
Citation (ISO format)
HEBEISEN, Monika et al. Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis. In: PLOS ONE, 2019, vol. 14, n° 5, p. e0216746. doi: 10.1371/journal.pone.0216746
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1932-6203
232views
81downloads

Technical informations

Creation12/05/2019 10:59:00 AM
First validation12/05/2019 10:59:00 AM
Update time11/09/2023 4:49:04 PM
Status update11/09/2023 4:49:04 PM
Last indexation02/12/2024 11:49:46 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack